Lifecore Biomedical Profit Margin

The latest profit margin for LNDC is -24.69% as of March 2026. That compares with 15.99% in the prior-year period — down 254.4% year over year. That is below the Materials sector average of 16.09%. Investors often review this figure alongside Lifecore Biomedical's historical trend and sector peers before judging valuation or financial health.

Over the past year, LNDC's profit margin moved from 15.99% to -24.69% — a 254.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Lifecore Biomedical's valuation or profitability profile.

Against Materials companies, LNDC currently prints -24.69% for profit margin, while the sector average sits near 16.09%. That is roughly 253.4% below the sector mean. Large gaps often invite a closer look at Lifecore Biomedical's growth, margins, and balance sheet.

Profit Margin shows how effectively Lifecore Biomedical converts resources into returns. At -24.69%, LNDC may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 15.99% in the prior-year period — down 254.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting LNDC's profit margin (-24.69%), review year-over-year change from 15.99%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.